SATELLITE SYMPOSIUM
(sponsored by 3Mensio)

IMAGING TO PLAN COMPLEX EVAR PROCEDURES
Chairmen : C. MIALHE (France) - D. GASPARINI (Italy)
Moderator : G. GILLING-SMITH (UK)

Topics :

. What do you need to know ?
R. WILLIAMS (UK)
. How do you get this information ? (Imaging requirements)
J. VAN DEN BERG (Switzerland)
. How accurately does 3D reconstruction represent reality ?
H. VERHAGEN (The Netherlands)

Panel Discussion :

M. THOMPSON (UK), P. BERERON (France), N. NUMAN(Turkey)

Faculty dinner

Welcome and opening ceremony
L.D. CASTELLANI (France)

Introduction : Opening lecture
Endovascular Therapy : a passing trend in the management of peripheral vascular disease
J. PALMAZ (USA)

Session I : CAROTID STENTING I PATIENT SELECTION
Chairmen : L. CASTELLANI - G.L. GILLING-SMITH
Moderator : M. MAKAROUN

TOPICS :

Anatomic criteria that determine technical difficulty and embolic risk
M. WHOLEY (USA)
The Delphi consensus : grading anatomic risk
R. WILLIAMS (UK)
Imaging to determine anatomic suitability
J. VAN DEN BERG (Switzerland)

PANEL DISCUSSION

C. SETACCI (Italy) - F. VEITH (USA)

Coffee Break

Session II : CAROTID STENTING II PATIENT SELECTION
Chairmen : P. BERGERON - J. BLEYN
Moderator : F. VEITH

Topics :

Do plaque characteristics determine risk for CAS
C. SETACCI (Italy)
Is there a role for virtual histology using IVUS ?
M. WHOLEY (USA)

Panel Discussion :

M. MAKAROUN (USA) - J. VAN DEN BERG (CH) - F. VAN ELST(Belgium)

Session III : Cost-effectiveness of EVAR
Chairmen : P. PEETERS - F. VEITH
Moderator : G.L. GILLING-SMITH

Topics :

How do we determine cost-effectiveness : a simple guide
F. VERMASSEN (BELGIUM)
Can we reduce the cost of follow up imaging ?
J. BLANKENSTEIJN (The Netherlands)
Can we reduce the cost of secondary intervention ?
G.L ; GILLING-SMITH (UK)
Can we reduce the cost of endografts ?
E. HOFF (USA)

Discussion
M. THOMPSON (UK) - J. BLEYN (Belgium) - P. BERGERON (France) - C. MIALHE (France)

Lunch for all participants / Social activities.

Session IV : MEET THE EXPERTS « HOW I DO IT ? »

How do I perfom CAS ? 2.30 pm - 3.00 pm
  M.Wholey (USA)
  How I treat endoleaks ? 3.00 pm - 3.30 pm
  G.White (Australia)
  How and when I place a Caval filter ? 3.30 pm - 4.00 pm
  Cl. Schönholz (USA)
  How do I treat Task D lesions in SFA ? 4.00 pm - 4.30 pm
  P.Peeters (Belgium)
  How do I treat Renal Artery Aneurysms ? 4.00 pm - 5.00 pm
  C.Setacci (Italy)

• BREAK

SESSION V : CASE REVIEW SESSION
Chairmen : M. THOMPSON - A. BRAY
Moderator : F. NUMAN

Theme :

(T) EVAR, carotid stenting, lower limb interventions

New debranching procedures for thoraco abdominal aneurysms
P. BERGERON (France)

Avoiding mesenteric ischemia when performing evar in a patient with visceral artery disease
F. VEITH (USA)

A difficult iliac aneurysm in an inoperable patient with marked iliac tortuosity
F. VEITH (USA)

AAA Excluder with deployment of the controlateral limb outside the main body of the graft
J. BLEYN (Belgium)

Endovascular treatment of renal artery aneurysm” A new alternative technique
F. VAN ELST (Belgium)

Management of Infected Aneurysmal Sac after TEVAR
H. ARBATLI (Turkey)

Retrograde recanalisation of a total occlusion of the SFA using a profunda femoris collateral
F. VERMASSEN (Belgium)

Retrograde recanalisation of the celiac trunk in a patient with type B dissection
J. VAN DEN BERG (CH)

Open or Endovascular repair of Aortic dissection
M. THOMPSON (UK)

Discussion

Free Evening

Session VI : LOWER LIMB INTERVENTIONS
Chairmen : J. WATELET - J. PALMAZ
Moderator : J.M. CARDON

Topics :

  How should we treat SFA disease in claudicants ?
P. PEETERS (Belgium)
  BTK disease-endovascular treatment strategy ?
K. DELOOSE (Belgium)
  The next frontier : kissing stents for the femoral bifurcation
M. AKESSON (Sweden)

Discussion :

(focussing on surveillance of lower limb interventions (with brief introduction by J. VAN DEN BERG))

A. BRAY (Australia) - J. BLEYN (Belgium) - F. VEITH (USA) - A. NEVELSTEEN (Belgium)

Coffee Break

Session VII : TEVAR FOR CHRONIC TYPE B DISSECTION
Chairmen : J.P VERHOYE - Y. OKITA
Moderator : P.BERGERON

Topics :

Is there any evidence that aneurysmal dilatation following chronic dissection requires intervention (risk of rupture)
M. THOMPSON (UK)
I ntervention for chronic dissection : what are we trying to achieve and how can we achieve this ?
L. LONN (Denmark)

Discussion :

M. MAKAROUN (USA) - C. MIALHE (France)

Session VIII : SPONSORS SESSION
Chairmen : J. BUSQUET - J.P. RIBAL
Moderator : F. VEITH

Presentating sponsors :

Medtronic - M. MAKAROUN
The Endurant stentgraft
Cordis - W. LANSINK
Endovascular treatment in below the knee : options and challenges
Saint-Jude - M. MANZI
Angio-seal versus manual compression in peripheal interventions
Bolton - V. RIAMBAU
Update on European Experience with Relay Thoracic Endograft
Lombard - J. MACIEREWICZ
Patient Shaped Technology : an update on the Aortofix (tm) Endovascular Stent Graft

Discussion

Lunch for all participants/ Social activities

MEET THE EXPERTS « TIPS AND TRICKS »

Unusual solutions to unusual problems
  In CAS 2.30 pm - 3.00 pm
M.Makaroun (USA)
  In lower limb interventions 3.00 pm - 3.30 pm
K.Deloose (Belgium)
  Renal artery stenosis 3.30 pm - 4.00 pm
C.Rabbia (Italy)
  In type B Dissection 4.00 pm - 4.30 pm
J.Brunkwall (Germany)
  In ruptured AAAs 4.30 pm - 5.00 pm
F.Veith (USA)

Pause

Session X : VARICOSE VEINS / ENDOVENOUS THERAPY
Chairmen : F. VAN ELST - J. NATALI
Moderator : J. BLEYN

Topics :

Venous disease :
Endovenous treatment of pulmonary embolism :
E.K. WEDELL (Germany)
Thrombolysis in acute deep venous thrombosis
N. BAEKGAARD (Denmark)

Varicose veins :
Is there still a place for classical vein stripping in 2008 ?
J. BLEYN (Belgium)
Comparison of new endovascular treatment of varicose veins ? (Foam, Laser, Radiofrequency)
J.L. GERARD (France)
Toward Consensus :
M. PERRIN (France)

Panel discussion

A. BASS (Israel)

Social dinner

Session XI : RENAL ARTERY STENOSIS
Chairmen : J.M. CARDON - D. GASPARINI
Moderator : J. VAN DEN BERG

Topics :

Results of randomized trials and current indications : a review
C. RABBIA (Italy)
Is there need for protection devices
G. de DONATO (Italy)

Discussion

Session XII : PHARMACOLOGY UPDATE-STROKE PREVENTION
Chairmen : G. CAMELOT - P. GOUNY
Moderator : M. WHOLEY

Topics :

Platelet inhibition : Symptomatic and asymptomatic
R. NAYLOR (UK)
Statins : Symptomatic and asymptomatic
R. WHITE (UK)

Discussion

Coffee Break

Session XIII : DEBATE
Moderator : L.C. CASTELLANI (France)

Motion :

Randomized trials do more harm than good

For the motion : J. BLANKENSTEIJN (The Netherlands)
Against the motion : J. PALMAZ (USA)

Dicussion

Against the motion : F. VEITH (USA)
For the motion : R. NAYLOR (UK)

Dicussion

Session XIV : CLOSING REMARKS AND SUMMARY OF THE WORKSHOP
T.V. SCHROEDER (Denmark)

ADJOURNMENT

Lunch (optional)